← Every company
Humacyte Inc Patents
What Humacyte Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
HUMA on carbonthat →Filings on file
4
Granted
0
Still pending
4
Filed under
3 names
4 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| DEVICES AND METHODS OF A MEDICAMENT-PRODUCING IMPLANTABLE MATRIXA61K 9/0024, A61L 27/3834, A61K 47/32, A61K 47/42, A61L 27/18, A61L 27/222, A61L 27/44, A61L 27/52, A61L 27/54, A61L2400/06, C08L 89/00, C08L 67/04Filed as Humacyte Global, Inc.2025-07-09Mehmet H. KURAL | pending |
| APPARATUS AND METHODS OF A TUBULAR TISSUE AS A THERAPEUTIC AGENT-PRODUCING SHEATH FOR A VASCULAR GRAFTA61F 2/06, A61L 27/507, A61F 2/852, A61L 27/18, A61L 27/3633, A61L 27/3891, A61L 27/52, A61L2430/34, C08L 67/04Filed as Humacyte, Inc.2024-11-05Mehmet Hamdi KURAL | pending |
| TISSUE-ENGINEERED CONSTRUCTSA61L 27/3633, C12N 5/0068, Y10T 156/1038, A61F 2/04, A61F 2/06, A61F2002/047, A61F2002/048, A61L 27/16, A61L 27/18, A61L 27/34, A61L 27/38, A61L 27/3895, A61L 27/54, A61L 27/58, B29C 53/005, B29C 53/36, B29K2067/043, B29K2105/256, B29K2995/0056, B29K2995/006, B29L2023/00, B29L2031/7532, C12N2533/30, C12N2533/40, C08L 67/04Filed as Humacyte Global, Inc.2024-11-01Shannon L.M. DAHL | pending |
| DEVICES AND METHODS OF A MEDICAMENT-PRODUCING IMPLANTABLE MATRIXFiled as HUMACYTE GLOBAL, INC.2024-01-11MEHMET H. KURAL | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on HUMA
Company overviewEverything on HUMA in one place, with the price.SEC filingsWhat HUMA's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat HUMA's own officers and directors buy and sell.Executive payWhat HUMA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in HUMA.Funds holding itWhich funds and ETFs hold HUMA, and how big a bet.LobbyingWhat HUMA spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HUMA's account, and who they worked for.